Skip to main content
NIH funding notice RFA-ES-15-016

NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)

Closed on November 13, 2017.

Posted
July 9, 2015
Close date
November 13, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,181,002 in first-year total cost, median $590,501.

Most frequent study sections

  1. Special Emphasis Panel[ZES1 LWJ-D (U4)]1
  2. Special Emphasis Panel[ZES1 LWJ-K (U4)]1

Most frequent institutions

  1. INTEGRATED LABORATORY SYSTEMS, LLC1
  2. MATTEK CORPORATION1
Competing awards under RFA-ES-15-016 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018CometChip: Development of a high throughput DNA damage assay in hepatocytes2U44ES024698-04ENGELWARD, BEVIN P.RECIO, LESLIEINTEGRATED LABORATORY SYSTEMS, LLC, NC$749,975ZES1
2017Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing2U44ES014312-04HAYDEN, PATRICK JMATTEK CORPORATION, MA$431,027ZES1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-ES-15-016: NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44) | ScienceDex | ConductScience